B4GAT1

Across TCGA pan-cancer cohorts, B4GAT1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated B4GAT1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher B4GAT1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated B4GAT1 expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.

CCRCC, PDAC, and LUAD are the cancer types where B4GAT1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	II,III,IV	0.729	0.915	.014	8	view →
PDAC	OS	Median	All	0.937	0.781	.032	8	view →
LUAD	OS	Quartile	All	0.910	1.000	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

B4GAT1–CCRCC (OS)

Open the CCRCC breakdown →